OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
KRTL
KRTL Holding Group, Inc
0.108
0.0031
2.96%
0.08 / 0.11 (1 x 1)
KRTL Holding Group Inc. (OTC: KRTL) is proud to announce the launch of the new website for its wholly owned subsidiary, KRTL Biotech Inc., located at www.krtlbiotech.com. The newly designed platform highlights KRTL Biotech's comprehensive suite of services aimed at supporting pharmaceutical companies across every stage of the product lifecycle.
KRTL Biotech's innovative approach combines operational excellence with industry-leading expertise, offering tailored solutions to optimize processes, mitigate risks, and accelerate success in delivering life-changing therapies. With a commitment to empowering pharmaceutical companies, the company specializes in a wide array of services, including:
- Quality Control & Quality Assurance
- Product Labeling & Compliance
- Supply Chain & Logistics
- Manufacturing Services
- U.S. Agent Representation
- Import & Export Logistics
- Regulatory Registration & Compliance
The website offers an easy-to-navigate interface, showcasing KRTL Biotech's commitment to delivering streamlined solutions for pharmaceutical development, manufacturing, and distribution. Visitors can explore the company's expertise, learn about its capabilities, and discover how KRTL Biotech supports the pharmaceutical industry in achieving operational success.
"Our new website reflects KRTL Biotech"s dedication to driving innovation and efficiency in the pharmaceutical industry," said Cesar Herrera. "We are proud to provide comprehensive services that help pharmaceutical companies overcome complex challenges and deliver life-changing therapies quickly, safely, and reliably."
To explore KRTL Biotech’s full range of services, visit www.krtlbiotech.com.
About KRTL Biotech Inc.:
KRTL Biotech Inc., a wholly owned subsidiary of KRTL Holding Group Inc., specializes in pharmaceutical registration, regulatory compliance, and the development of pharmaceutical products and APIs. KRTL Biotech is dedicated to innovation and operational excellence in the pharmaceutical industry.
About KRTL Holding Group, Inc.
We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
KRTL Holding Group Inc., a holding company which operates through its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp. These subsidiaries have evolved to focus on distinct industries, yet they intricately intertwine, forming the bedrock of the KRTL brand. This strategic synergy empowers KRTL Holding Group to actively pursue investment opportunities and forge invaluable partnerships, ultimately enhancing shareholder value.
Additional information on KRTL is available online at www.krtlholding.com and www.krtl-icc.com and www.krtlbiotech.com.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
